FDA leaders say they appreciate financial support for federal precision medicine efforts, but are wary of any efforts by Congress to insert new authorities and mandates to how the agency regulates personalized medicine and diagnostics.
The latest discussion draft of the House 21st Century Cures legislation includes increased research funding for the National Institutes of Health , which both NIH and FDA leaders praised at...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?